| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |